1-20 of 21
Henry Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P103: The introduction of a single strain of Bacillus into a germ-free environment did not impact the anti-PD-1 efficacy in a MC38 syngeneic model

Tao Yang, Bonnie Xiaobo Chen, Rongfei Lu, Xiaoyu An, Mingfa Zang, Jingjun Li, Sheng Guo, Wubin Qian, Jian Fei, Tongyang Hao, Edward Xu, Henry Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P103.
DOI: https://doi.org/10.1158/1535-7163.TARG-21-P103
Published: 01 December 2021
View article
Journal Articles

Abstract P003: In vitro and in vivo characterization of CCR8 humanized mouse model (HuGEMM™)

Daniel He, Henry Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P003.
DOI: https://doi.org/10.1158/1535-7163.TARG-21-P003
Published: 01 December 2021
View article
Journal Articles

Abstract C118: Transcriptome comparison of orthotopic and subcutaneous patient-derived xenografts

xiaoqian jiang, henry li, sheng guo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): C118.
DOI: https://doi.org/10.1158/1535-7163.TARG-19-C118
Published: 01 December 2019
View article
Journal Articles

Abstract A025: Comparative analysis of proteomic/transcriptomic profiles of a panel of GC-PDXs

Binchen Mao, Sheng Guo, Bonnie Xiaobo Chen, Davy Xuesong Ouyang, Henry Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): A025.
DOI: https://doi.org/10.1158/1535-7163.TARG-19-A025
Published: 01 December 2019
View article
Journal Articles

Abstract C054: Discovery of KYM-003, a potent and selective STAT3 degrader with antitumor activity in heme malignancies

Fred Csibi, Nan Ji, Bin Yang, Karen Yuan, Michele Mayo, Haojing Rong, Scott Rusin, Kirti Sharma, Christine Loh, Henry Li, Sharon Townson, Hari Kamadurai, Jesse Chen, Duncan Walker, Jared Gollob, Nello Mainolfi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): C054.
DOI: https://doi.org/10.1158/1535-7163.TARG-19-C054
Published: 01 December 2019
View article
Journal Articles

Abstract B142: Co-culture of tumor organoids with immune cells for immuno-oncology drug development

Zhongliang Li, Jun Zhou, Rui Zhang, Fei Wang, Shuzong Wang, Xiaoxi Xu, Yujun Huang, Henry Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): B142.
DOI: https://doi.org/10.1158/1535-7163.TARG-19-B142
Published: 01 December 2019
View article
Journal Articles

Abstract C82: Induction of resistances to crizotinib in lung patient derived xenograft

Jianyun Deng, Zhun Wang, Jie Cai, Sheng Guo, Jean-Pierre Wery, Henry Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): C82.
DOI: https://doi.org/10.1158/1535-7163.TARG-15-C82
Published: 01 December 2015
View article
Journal Articles

Abstract A11: HuGEMM-h/mPD1 mouse models for assessing anti-human PD1 therapeutics

Zhun Wang, Bin Cai, GANG Chen, Jinping Liu, Xiaoyu An, Zhengsheng Wang, Davy Ouyang, Jean-Pierre Wery, Jay Liu, Xin Dong, Henry Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): A11.
DOI: https://doi.org/10.1158/1535-7163.TARG-15-A11
Published: 01 December 2015
View article
Journal Articles

Abstract C173: Anti-PD-L1 antibody-based IL-15 immunocytokine has enhanced antitumor immunity

Yan Wu, Zhaojing Zhong, Stella Martomo, Dan Lu, Zhanna Polonskaya, Xenia Luna, Haifan Zhang, Zhikai Zhang, Zhun Wang, Leo Liu, Jeegar Patel, James Tonra, Henry Li, Larry Witte, Sam Waksal, Zhenping Zhu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): C173.
DOI: https://doi.org/10.1158/1535-7163.TARG-15-C173
Published: 01 December 2015
View article
Journal Articles

Abstract B97: Response to checkpoint inhibition by GEMM breast cancer allograft

Zhun Wang, Xiaoyu An, Jinping Liu, Jie Cai, Likun Zhang, Jiagui Qu, Davy Ouyang, Bin Chen, Jean-Pierre Wery, Henry Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): B97.
DOI: https://doi.org/10.1158/1535-7163.TARG-15-B97
Published: 01 December 2015
View article
Journal Articles

Abstract B101: Molecular pathology of patient derived xenografts

Sheng Guo, Wubin Qian, Jie Cai, Likun Zhang, Jean-Pierre Wery, Henry Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): B101.
DOI: https://doi.org/10.1158/1535-7163.TARG-15-B101
Published: 01 December 2015
View article
Journal Articles

Abstract A145: In vivo and in vitro generation and characterization of EGFR TKI resistance in a patient-derived and a cell line-derived xenograft model of NSCLC with activating EGFR mutations.

Andrew J. McKenzie, Aaron N. Cranston, Nektaria Papadopoulou, Simon Jiang, Jane Wrigley, Yinfei Yin, Henry Li, Martin Page, Rajendra Kumari
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A145.
DOI: https://doi.org/10.1158/1535-7163.TARG-13-A145
Published: 01 November 2013
View article
Journal Articles

Abstract B43: A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy.

Lianhai Zhang, Jie Yang, Yiyou Chen, Jie Cai, Xiaoming Song, Xuesong Huang, Jianyun Deng, Dawei Chen, Mengmeng Yang, Shuangxi Li, Aiwen Wu, Ziyu Li, Zhongwu Li, Yiqian Liu, Jean-Pierre Wery, Henry Li, Jiafu Ji
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B43.
DOI: https://doi.org/10.1158/1535-7163.TARG-13-B43
Published: 01 November 2013
View article
Journal Articles

Abstract A91: Activating EGFR mutation, G719A, was selected in the c-MET amplified NSCLC-PDX-LU1901 during the treatments by c-MET inhibitors and the resistance development.

Mengmeng Yang, Jie Cai, Sheng Guo, Shijun Yu, Wubin Qian, Xiaoming Song, Youzhu Wang, Jean-Pierre Wery, Henry Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A91.
DOI: https://doi.org/10.1158/1535-7163.TARG-13-A91
Published: 01 November 2013
View article
Journal Articles

Abstract C14: Squamous non-small cell lung cancer (NSCLC-SCC) patient-derived xenografts (PDX) from Asian patients have high response rate (RR) to cetuximab than those of adenocarcinoma.

Mengmeng Yang, Jie Cai, Sheng Guo, Xuesong Huang, Jie Yang, Xiaoming Song, Dawei Chen, Likun Zhang, Jiahua Jiang, Jean-Pierre Wery, Henry Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): C14.
DOI: https://doi.org/10.1158/1535-7163.TARG-13-C14
Published: 01 November 2013
View article
Journal Articles

Abstract A157: Metastatic PDX modeling displays correlation between CTC and metastatic potential, both inhibited by chemotherapy.

Jiahua Jiang, Daisy D. Wang, Mengmeng Yang, Dawei Chen, Sheng Guo, Jie Cai, Linda Li, Jean-Pierre Wery, Peter Ping Lin, Henry Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A157.
DOI: https://doi.org/10.1158/1535-7163.TARG-13-A157
Published: 01 November 2013
View article
Journal Articles

Abstract A142: In vivo response and molecular characterization of a Caucasian NSCLC squamous cell carcinoma PDX sensitive to FGFR inhibitor.

Andrew J. McKenzie, Aaron N. Cranston, Nektaria Papadopoulou, Simon Jiang, Jane Wrigley, Yinfei Yin, Henry Li, Martin Page, Rajendra Kumari
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A142.
DOI: https://doi.org/10.1158/1535-7163.TARG-13-A142
Published: 01 November 2013
View article
Journal Articles

Abstract C113: Modeling cetuximab clinical trial by conducting in vivo efficacy evaluation in large panel CRC patient-derived xenograft (PDX) models.

Dawei Chen, Mengmeng Yang, Jiangyun Deng, Xiaoming Song, Jie Cai, Taiping Chen, Yiyou Chen, Henry Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): C113.
DOI: https://doi.org/10.1158/1535-7163.TARG-11-C113
Published: 12 November 2011
View article
Journal Articles

Abstract B36: Exploring potential clinical application of cetuximab in NSCLC: Efficacy study in a large panel patient derived xenograft (PDX) model.

Mengmeng Yang, Dawei Chen, Jie Yang, Jiangyun Deng, Xiaoming Song, Jie Cai, Taiping Chen, Yiyou Chen, Henry Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): B36.
DOI: https://doi.org/10.1158/1535-7163.TARG-11-B36
Published: 12 November 2011
View article
Journal Articles

Abstract C9: Response to cetuximab is associated with EGFR gene amplification in gastric cancinoma patient derived xenograft models.

Jie Yang, Dawei Chen, Mengmeng Yang, Jiangyun Deng, Xiaoming Song, Jie Cai, Taiping Chen, Henry Li, Yiyou Chen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): C9.
DOI: https://doi.org/10.1158/1535-7163.TARG-11-C9
Published: 12 November 2011
View article